look at the MMPI-2 profiles of medically ill patients, Graham suggested that profiles of medical patients fall within the normal limits, with T-scores on scales 1 (hypochondriasis (Hs)), 2 (depression (D)), and 3 (hysteria (Hy)) falling between 55 and 60 and scores on the rest of the clinical scales falling near the mean. 3 O s b o r n e 4 summarized studies with the original MMPI. He concluded that patients whose symptoms were primarily psychological in origin tended to score higher on scales 1 (Hs), 2 (D), and 3 (Hy) compared to patients with similar symptoms of an o rganic origin. Furthermore, the most common profile among those patients was a "V" profile with scales 1 (Hs) and 3 (Hy) being more elevated than scale 2 (D). The likelihood of functional origin increased when scales 1 (Hs) and 3 (Hy) were elevated above a score of T-65 and were considerably higher than scale 2 (D).
METHOD
The hospital charts and brain CT-scans of 85 patients who received IV r t -PA for acute stroke were reviewed as part of an auditing and follow-up program by a team of two neurologists and a neuroradiologist who were not involved with the acute management of the patient whose chart and imaging studies were being reviewed. The neuroradiologist was blinded to clinical presentation and outcome. All the surviving patients underwent neurological re-examination at least three months after thrombolytic therapy. Based on inconsistencies in the initial clinical presentation, follow-up neurological examination, and imaging studies, two patients were identified as possibly suffering from somatoform disorder. Both patients underwent psychological consented neurological reexamination, MMPI-2 testing and electroencephalography. Each case was further discussed with the physicians involved with their care at the time of acute presentation in order to understand further the acute presentation and the reasoning that led to thrombolytic treatment.
Patient 1
An 81-year-old right-handed woman with a past medical history of seizures and pseudoseizures was brought to the emergency room with an acute left arm and leg paralysis and sensory loss. Her neurological examination revealed full visual fields, severe dysarthria, paralysis and sensory loss on the left. Her National Institute of Health Stroke Scale score (NIHSS-score) was 13. Brain CTrevealed no changes attributable to acute stroke. This presentation was interpreted as an acute stroke in the right middle cerebral artery territory. Considering that she was within the three hour window, she was treated with IV rt-PA. Her symptoms completely resolved within six hours. The evening of her hospital stay she called the nurse to her bedside, became unresponsive and her eyes rolled up and down for a few minutes. Immediately thereafter, she regained a normal level of consciousness and told the nurse that she just had a seizure. There was no post-ictal state. During the next three months she made four more emergency room visits with similar claims of having a stroke. At one of these presentations she demanded thrombolytic therapy, and at another she demonstrated left-sided paralysis in the presence of physicians, but she was able to use her left arm when not under direct observation.
Following her last presentation, the MMPI-2 was administered and the patient provided a valid profile. All subscales were within the normal limits with the exception of scales 1 (Hs), 2 (D), and 3 (Hy). T-scores for scales 1 and 3 were greater than 65 and considerably higher than scale 2. The patient denied any recent stressors. This patient's profile was consistent with a diagnosis of conversion disorder.
Patient 2
A 52-year-old right-handed man with a history of depression was brought to the emergency room with sudden onset of left-sided paralysis and speech arrest. He was awake and oriented but anarthric, had full visual fields and demonstrated inconsistent and ever changing eye movement abnormalities, bilateral facial weakness, paralysis of all limbs, and sensory loss on the left. An NIHSS-score of 26 was given. Brain CT revealed no acute changes. He was clinically diagnosed with brainstem stroke. A decision was made to attempt intravenous and intraarterial rt-PA. As part of this protocol, a cerebral angiogram was performed revealing no clot or vascular pathology. He remained with weakness fluctuating from day to day. He was later referred to rehabilitation. Six months later, he presented with another acute episode identical to the first one, with the addition of trismus. The patient was examined by another set of physicians and underwent the same diagnostic and treatment steps with similar results. He was again transferred to rehabilitation with left sided deficits. Two months later at a stroke clinic follow-up, he continued to claim and demonstrate severe left sided weakness and diminished sensation on the left, which split right in the midline. He showed difficulty lifting his left arm and leg against gravity, but when asked, he was able to walk backward on his toes with his knees bent at 90 degrees and his hands held over his head. At a third presentation to the emergency room he was mute, unresponsive to verbal commands, and resisted attempts by the examiner to open his eyes or mouth. His left arm elevated over his face, gently dropped down to the bed. Brain CT showed no abnormality. He was admitted to the psychiatry unit. Two months later he was discharged with an axis I diagnosis of somatoform disorder, and axis II diagnosis of dependent traits.
The MMPI-2 test was administered and again a valid profile was provided by the patient. Scales 1 (Hs), 2 (D), and 3 (Hy) were elevated. This patient's profile was consistent with a diagnosis of hypochondriasis.
DISCUSSION
Within the narrow time window for thrombolytic treatment, rapid but accurate neurological assessment is essential when confronted with an acute stroke syndrome. 4 We have summarized two patients with several presentations suggestive of acute vascular events where IV rt-PA was incorrectly given in three events. Both patients were later diagnosed with somatoform disorders. This is disconcerting in light of the serious hemorrhagic complications of rt-PA . 5 I n t r a c r a n i a l hemorrhage risk was 6.3% in the National Institute of Neurological Disorders and Stroke trial. Interestingly, 20% of all rt-PA related symptomatic hemorrhages (1.3% of all rt-PA treated patients) occurred in a vascular territory outside of the presenting stroke. 6 Although higher rt-PA doses and addition of heparin and or aspirin were used in thrombolytic therapies for myocardial infarction, hemorrhagic strokes occurred in 0.95% of these patients. 7 Both of our patients presented with recurring events. Missing the diagnosis of a somatoform disorder may have contributed to reinforcing the patients'symptoms and thus propagating further symptoms and delayed appropriate treatment.
Screening questionnaires for somatization disorder have been developed. Patients with a history of three or more symptoms of shortness of breath, dysmenorrhea, burning in sex organs, lump in throat, amnesia, vomiting and painful extremities are at risk for somatization disorder. 8 Neurologists often use Weintraub's physical signs of hysteria including la belle indifference, sensory loss not conforming to anatomical patterns, changing patterns of sensory loss, alterations of sensory and motor findings with suggestion, hemianesthesia that splits the midline, unilateral loss of vibratory sense when two sides of forehead or sternum are stimulated and give away weakness on motor testing. 9 The validity of such signs has been questioned. 10 While waiting for laboratory results, there is sufficient time to more carefully ascertain such neurological findings and identify whether the stroke syndrome reflects the suspected vascular territory. In the future, more advanced imaging techniques such as diffusion perfusion MRI may aid the identification of those whose clinical presentation cannot be explained anatomically.
Besides somatoform disorder, other neurological disorders such as seizures, multiple sclerosis, migraine aura, and brain tumors may have acute stroke-like presentations. It is possible that our patients experienced transient ischemic attacks (TIAs), which may explain why follow-up brain CT failed to demonstrate a lesion compatible with stroke. Given the reoccurrence of identical symptoms and inconsistencies in neurological examination, the possibility of TIAs is remote. Postictal state is a consideration in the first patient. However, no seizure activity or postictal changes were demonstrated on EEG, and recovery from presumed generalized seizures was rapid and complete, making seizures unlikely.
In the emergency room, somatoform disorder is a diagnosis of exclusion. Careful self-auditing by acute stroke programs may help to distinguish patients with acute stroke from those with somatoform disorders. This may help to develop distinct patient profiles to prevent inadvertent use of thrombolytic therapy. However, it is important to emphasize that even patients with a previous diagnosis of somatoform disorder need to be accurately assessed each time they present with an acute stroke-like syndrome. Like the general population, people with somatoform disorder still remain at risk for stroke.
